Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study

Guidet, Bertrand; Martinet, Olivier; Boulain, Thierry; Philippart, Francois; Poussel, Jean Francois; Maizel, Julien; Forceville, Xavier; Feissel, Marc; Hasselmann, Michel; Heininger, Alexandra; Van Aken, Hugo

dc.contributor.author	Heininger, Alexandra	de_DE
dc.date.accessioned	2014-06-03T13:43:23Z
dc.date.available	2014-06-03T13:43:23Z
dc.date.issued	2012	de_DE
dc.identifier.issn	1466-609X	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/53347
dc.language.iso	en	en
dc.publisher	Biomed Central Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1186/cc11358	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_03616	de_DE
utue.personen.roh	Guidet, Bertrand	de_DE
utue.personen.roh	Martinet, Olivier	de_DE
utue.personen.roh	Boulain, Thierry	de_DE
utue.personen.roh	Philippart, Francois	de_DE
utue.personen.roh	Poussel, Jean Francois	de_DE
utue.personen.roh	Maizel, Julien	de_DE
utue.personen.roh	Forceville, Xavier	de_DE
utue.personen.roh	Feissel, Marc	de_DE
utue.personen.roh	Hasselmann, Michel	de_DE
utue.personen.roh	Heininger, Alexandra	de_DE
utue.personen.roh	Van Aken, Hugo	de_DE
dcterms.isPartOf.ZSTitelID	Critical Care	de_DE
dcterms.isPartOf.ZS-Issue	Article R94	de_DE
dcterms.isPartOf.ZS-Volume	16	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE